SS
DGX icon

SBI Securities’s Quest Diagnostics DGX Stock Holding History

SBI Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.3K Buy
374
+1
+0.3% +$196 ﹤0.01% 998
2026
Q1 		$73.1K Buy
373
+25
+7% +$4.86K ﹤0.01% 955
2025
Q4 		$60.4K Buy
348
+4
+1% +$728 ﹤0.01% 1013
2025
Q3 		$65.6K Sell
344
-12
-3% -$2.13K ﹤0.01% 983
2025
Q2 		$63.9K Hold
356
– – ﹤0.01% 966
2025
Q1 		$60.2K Sell
356
-4
-1% -$657 ﹤0.01% 915
2024
Q4 		$54.3K Buy
+360
New +$56K ﹤0.01% 958

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

SBI Securities's DGX Position: Q2 2026 in Review

SBI Securities increased its Quest Diagnostics (DGX) stake by 0.27% in Q2 2026, buying an estimated $196 and bringing the position to 374 shares worth $79.3K. The position accounts for ﹤0.01% of the portfolio, ranked #998.

SBI Securities first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • SBI Securities held 374 shares of Quest Diagnostics worth $79.3K as of Q2 2026.
  • SBI Securities bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
  • Quest Diagnostics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #998 holding.
  • SBI Securities first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.